Literature DB >> 8921969

Characterization of H4: a mouse T lymphocyte activation molecule functionally associated with the CD3/T cell receptor.

V Redoglia1, U Dianzani, J M Rojo, P Portolés, M Bragardo, H Wolff, D Buonfiglio, S Bonissoni, C A Janeway.   

Abstract

The monoclonal antibody C398.4A was produced by immunizing Armenian hamsters with the mouse T cell clone D10.G4.1. It recognizes a molecule selectively expressed by activated mouse T cells and was named H4. H4 is expressed on the T cell surface about 24 h after activation and peaks at day 7. By contrast, it is not expressed by resting or activated B cells, macrophages, or fibroblasts. It is also expressed by CD4 or CD8 single-positive mature thymocytes. Immunoprecipitation showed that H4 is a disulfide-linked dimer, precipitating as a broad band at about 50-65 kDa under nonreducing conditions and at 25 and 29 kDa under reducing conditions. Deglycosylation of the reduced H4 by N-glycanase gave rise to a single band of about 21 kDa, suggesting that the two chains may be differentially glycosylated forms of the same protein. The H4 expression pattern and biochemical features, together with cross-blocking, co-capping, co-modulation, and immunoprecipitation preclearing experiments showed that H4 is different from other known co-stimulatory molecules such as CD69, CD2, Ly-6, CD25, OX-40, Mac-1 and LFA-1. By in vitro kinase assay, H4 was found to co-precipitate a tyrosine kinase activity that phosphorylated substrates of about 29 and 25 kDa. Co-modulation and co-capping experiments showed that H4 is physically associated with the CD3/T cell receptor. These data suggest that H4 may function as a T cell-specific co-stimulatory molecule and play a role in the T cell response when the activation stimulus is limited either because the antigen is only available in low concentration or has a low agonistic activity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8921969     DOI: 10.1002/eji.1830261134

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  14 in total

1.  Biased binding of class IA phosphatidyl inositol 3-kinase subunits to inducible costimulator (CD278).

Authors:  Yenny Y Acosta; Maria Paz Zafra; Gloria Ojeda; Ilaria Seren Bernardone; Umberto Dianzani; Pilar Portolés; Jose M Rojo
Journal:  Cell Mol Life Sci       Date:  2010-12-28       Impact factor: 9.261

2.  ICOS, CD40, and lymphotoxin beta receptors signal sequentially and interdependently to initiate a germinal center reaction.

Authors:  Frances Vu; Umberto Dianzani; Carl F Ware; Tak Mak; Jennifer L Gommerman
Journal:  J Immunol       Date:  2008-02-15       Impact factor: 5.422

3.  Role for inducible costimulator in control of Salmonella enterica serovar Typhimurium infection in mice.

Authors:  Mariana Vidric; Anna Tafuri Bladt; Umberto Dianzani; Tania H Watts
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

4.  Inducible costimulator is essential for collagen-induced arthritis.

Authors:  Roza I Nurieva; Piper Treuting; Julie Duong; Richard A Flavell; Chen Dong
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

5.  Inducible costimulator promotes helper T-cell differentiation through phosphoinositide 3-kinase.

Authors:  Mathieu Gigoux; Jijun Shang; Youngshil Pak; Minghong Xu; Jongseon Choe; Tak W Mak; Woong-Kyung Suh
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-13       Impact factor: 11.205

6.  Attenuation of immune-mediated influenza pneumonia by targeting the inducible co-stimulator (ICOS) molecule on T cells.

Authors:  Priya Sakthivel; Marcus Gereke; Angele Breithaupt; Dietmar Fuchs; Luca Gigliotti; Achim D Gruber; Umberto Dianzani; Dunja Bruder
Journal:  PLoS One       Date:  2014-07-16       Impact factor: 3.240

7.  Development of interleukin-17-producing Vγ2+ γδ T cells is reduced by ICOS signaling in the thymus.

Authors:  Terkild Brink Buus; Jonas Damgård Schmidt; Charlotte Menné Bonefeld; Carsten Geisler; Jens Peter Holst Lauritsen
Journal:  Oncotarget       Date:  2016-04-12

8.  T-Cell-Specific Loss of the PI-3-Kinase p110α Catalytic Subunit Results in Enhanced Cytokine Production and Antitumor Response.

Authors:  Laura Aragoneses-Fenoll; Gloria Ojeda; María Montes-Casado; Yeny Acosta-Ampudia; Umberto Dianzani; Pilar Portolés; José M Rojo
Journal:  Front Immunol       Date:  2018-02-27       Impact factor: 7.561

9.  The PI-3-Kinase P110α Catalytic Subunit of T Lymphocytes Modulates Collagen-Induced Arthritis.

Authors:  María Montes-Casado; Gloria Ojeda; Gabriel Criado; José M Rojo; Pilar Portolés
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923

Review 10.  Osteopontin at the Crossroads of Inflammation and Tumor Progression.

Authors:  Luigi Mario Castello; Davide Raineri; Livia Salmi; Nausicaa Clemente; Rosanna Vaschetto; Marco Quaglia; Massimiliano Garzaro; Sergio Gentilli; Paolo Navalesi; Vincenzo Cantaluppi; Umberto Dianzani; Anna Aspesi; Annalisa Chiocchetti
Journal:  Mediators Inflamm       Date:  2017-07-09       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.